It was interesting to note that evogliptin reduced the calcium deposition in vivo in both eNOS−/− mice (Figure 1) and in a rabbit CAVD model (Figure 5). The gene discussed is NOS3; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.